Abstract
Insulin-dependent diabetes mellitus (IDDM) is a metabolic disease usually resulting from autoimmune-mediated β-cell destruction requiring lifetime exogenous insulin replacement. Mesenchymal stem cells (MSC) hold promising therapy. We present our experience of treating IDDM with co-infusion of in vitro autologous adipose tissue-derived MSC-differentiated insulin-secreting cells (ISC) with hematopoietic stem cells (HSC). This was an Institutional Review Board approved prospective non-randomized open-labeled clinical trial after informed consent from ten patients. ISC were differentiated from autologous adipose tissue-derived MSC and were infused with bone marrow-derived HSC in portal, thymic circulation by mini-laparotomy and in subcutaneous circulation. Patients were monitored for blood sugar levels, serum C-peptide levels, glycosylated hemoglobin (Hb1Ac) and glutamic acid decarboxylase (GAD) antibodies. Insulin administration was made on sliding scale with an objective of maintaining FBS < 150 mg/dL and PPBS around 200 mg/dL. Mean 3.34 mL cell inoculums with 5.25 × 104 cells/μL were infused. No untoward effects were observed. Over a mean follow-up of 31.71 months, mean serum C-peptide of 0.22 ng/mL before infusion had sustained rise of 0.92 ng/mL with decreased exogenous insulin requirement from 63.9 international units (IU)/day to 38.6 IU/day. Improvement in mean Hb1Ac was observed from 10.99 to 6.72 %. Mean GAD antibodies were positive in all patients with mean of 331.10 IU/mL, which decreased to mean of 123 IU/mL. Co-infusion of autologous ISC with HSC represents a viable novel therapeutic option for IDDM.
Similar content being viewed by others
Abbreviations
- BM:
-
Bone marrow
- CBM:
-
Cultured bone marrow
- DKA:
-
Diabetic ketoacidosis
- FBS:
-
Fasting blood sugar levels
- GAD:
-
Glutamic acid decarboxylase
- Hb1Ac:
-
Glycosylated hemoglobin
- HSC:
-
Hematopoietic stem cells
- ISC:
-
Insulin-secreting cells
- MSC:
-
Mesenchymal stem cells
- PPBS:
-
Postprandial blood sugar level
- IDDM:
-
Insulin-dependent diabetes mellitus
References
Starzl TE (2001) The “privileged” liver and hepatic tolerogenicity. Liver Transpl 7(10):918–920
Sprent J, Kishimoto H (2001) The thymus and central tolerance. Philos Trans R Soc Lond B Biol Sci 356(1409):609–616
Castano L, Eisenbarth GS (1990) Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647–679
Dave SD, Vanikar AV, Trivedi HL (2012) Ex vivo generation of glucose sensitive insulin secreting mesenchymal stem cells derived from human adipose tissue. Indian J Endocr Metab 16(1):S65–S69
Trivedi HL, Vanikar AV, Thakker UG, Feroze A, Dave SD et al (2008) Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transpl Proc 40(4):1135–1139
Vanikar AV, Dave SD, Thakkar UG, Trivedi HL (2010) Co-transplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int Article ID 582382 5 pages
Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH et al (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999–8004
Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB et al (2000) Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6:278–282
Yang L, Li S, Hatch H, Ahrens K, Cornelius JG et al (2002) In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 99:8078–8083
Suzuki A, Nakauchi H, Taniguchi H (2002) Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 100:5034–5039
Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA et al (2000) Insulin secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157–162
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R et al (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389–1394
Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL et al (2001) Insulin production by human embryonic stem cells. Diabetes 50:1691–1697
Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/SCID mice. Proc Natl Acad Sci 103:17438
Urban VS, Kiss J, Kovacs J, Gocza E, Vas V et al (2008) Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26:244–253
Brusko TM (2009) Mesenchymal stem cells: a potential border patrol for transplanted islets? Diabetes 58(8):1728–1729
Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH (2008) Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for insulin dependent diabetes. Diabetes 57:1759–1767
Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499–3506
Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML (2010) Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43:255–263
da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(11):2204–2213
Zhang N, Li J, Luo R, Jiang J, Wang JA (2008) Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes 116:104–111
Couri CEB, Voltarelli JC (2009) Stem cell therapy for insulin dependent diabetes mellitus: a review of recent clinical trials. Diabetol Metab Syndr 1:19
Timper K, Sebok D, Eberhardt M, Linscheid P, Christ-Crain M et al (2006) Human adipose-tissue derived mesenchymal stem cells differentiate into insulin, somatostatin and glucagon expressing cells. Biochem Biophys Res Commun 341(4):1135–1140
Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W et al (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50:521–533
Okura H, Komoda H, Fumimoto Y, Lee C, Nishida T et al (2009) Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs 12(2):123–130
Acknowledgments
The authors thank the staff and technicians of IKDRC-ITS, India, for all the technical help. The authors also thank Shobhana Sengunthar for providing statistical analysis.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dave, S.D., Vanikar, A.V., Trivedi, H.L. et al. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells. Clin Exp Med 15, 41–45 (2015). https://doi.org/10.1007/s10238-013-0266-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-013-0266-1